🇺🇸 FDA
Patent

US 10118932

Solid state forms of spiro-oxindole compounds

granted A61KA61K31/407A61P

Quick answer

US patent 10118932 (Solid state forms of spiro-oxindole compounds) held by Xenon Pharmaceuticals Inc. expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/407, A61P, A61P25/00, A61P25/08